Veeda Clinical Research Limited’s Post

"Thrilled to have presented my research at 72nd Indian Pharmaceutical Congress, Nagpur! Grateful for the opportunity to share my work and connect with brilliant minds in the field. Excited to continue exploring new insights and contributions. #Research #Conference #PosterPresentation"

𝑫𝒓𝒖𝒈 𝑫𝒊𝒔𝒄𝒐𝒗𝒆𝒓𝒚 𝑺𝒆𝒓𝒗𝒊𝒄𝒆𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝑷𝒓𝒐𝒋𝒆𝒄𝒕𝒆𝒅 𝒕𝒐 𝒃𝒆 𝑾𝒐𝒓𝒕𝒉 $41.3 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐟𝐨𝐫 𝐌𝐨𝐫𝐞 𝐃𝐞𝐭𝐚𝐢𝐥𝐬@ https://lnkd.in/dNbS-2vv The size of global drug discovery services market in terms of revenue was estimated to be worth $20.6 billion in 2023 and is poised to reach $41.3 billion by 2028, growing at a CAGR of 14.9% from 2023 to 2028. Leading Market Players: Labcorp Charles River Laboratories WuXi AppTec Thermo Fisher Scientific Pharmaron Beijing Evotec Eurofins Piramal Enterprises Limited Syngene International Limited Curia Global GenScript Jubilant Pharmova Limited Frontage Laboratories, Inc Shanghai Medicilonic Inc. Aurigene Discovery Technologies (Dr. Reddy's Laboratories) Sygnature Discovery Oncodesign Services Selvita Viva Biotech TCG Lifesciences Pvt Ltd. Domainex NUVISAN The Science CRO Dalton Pharma Services Aragen Life Sciences Promega Corporation #DrugDiscovery #Biotech #Pharmaceuticals #LifeSciences #HealthcareInnovation #Biotechnology #Pharma #ResearchAndDevelopment #DrugDevelopment #ClinicalResearch #MedicalResearch #CRO #PharmaIndustry #HealthTech #Biomedical #Therapeutics #Diagnostics #PersonalizedMedicine #Biopharma #InnovationInHealth

#TechnoteTuesday -This week, we're delving into pharmacopoeial methods, focusing on analyzing highly water-soluble drug delivery vehicles, explicitly using the PA 800. In pharmaceutical and biopharmaceutical industries, the utilization of compounds like Betadex as delivery vehicles has become paramount. These vehicles play a crucial role in ensuring the effective delivery of molecules that are challenging to dissolve or maintain stability until reaching their intended destination. While not designated as AAV, their significance lies in their ability to enhance bioavailability, particularly for drugs with limited solubility in water. Why is this important, you may ask? Well, it all boils down to USP specifications. The United States Pharmacopeia outlines capillary electrophoresis (CE) as the method for analysis, providing meticulous details on instrument conditions, capillary treatment, and separation parameters. Our latest technical note explores this methodology, employing the PA 800 plus system to adhere to the system suitability parameters mandated by USP. Establishing a robust assay ensures product quality and safety while maintaining batch-to-batch consistency. Since the debut of the first FDA-approved product containing Betadex sulfobutyl ether sodium, its derivative has been instrumental in countless drug formulations. Hence, our commitment to refining analytical methods aligns with industry standards and the ever-evolving landscape of pharmaceutical science. I invite you to explore our Technote as Xiaoxia Zhan, Tie Gao Hongxu Chen from Team SCIEX China, and Kai Xu from the National Institute for Food and Drug Control examine "Analyzing the average degree of substitution in betadex sulfobutyl ether sodium using capillary electrophoresis." #TechnoteTuesday #Biotherapeutics #innovation #biophase8800 #drugdevelopment #biotechnology #qualitycontrol #biotech #Biopharma #ProteinCharacterization #Innovation #cESDS #TherapeuticProteins #mabs #sciex #capillaryelectrophoresis #sciexforscience #genetherapy #rnatherapeutics #immunotherapy

One of the toughest challenges facing small molecule drug development today is poor solubility of the API. No single technique has universal application, so several strategies exist. Raj (Rajendran) Arunagiri examines 4 notable strategies in this article. https://lnkd.in/e-WyUmpc #smallmolecule #drugdevelopment #API

#SaveTheDate 📌  📅 May 22nd - 24th in 📍Acireale (CT), IT  🔸 the 31st GIQAR congress will be held in Acireale  💊 this edition will focus on #Quality, #compliance and new digital challenges.  👩🔬 GEM FORLAB S.r.L. will be represented by our Quality Assurance, Alessandra Giuliano Albo! In her speech she will talk about "Quality during the development of a medicinal product: ensuring data integrity in an integrated GLP/GCP system, between critical issues and opportunities  🔼More information here: https://lnkd.in/dmHBATjE #gemforlab #pharmaceutical #GLP #GCP #research #healthcare #proteomics #molecularbiology #chemistry #biology #event #Partnering #TechTransfer #Collaboration #Innovation #LifeSciences #Investment #pharmaindustry

BRIDGING INDUSTRY AND ACADEMIA: MoU with Greyhound Chromatography I am thrilled to announce a landmark Memorandum of Understanding (MoU) between CHALAPATHI DRUG TESTING LABORATORY (CDTL), CHALAPATHI NAGAR, LAM, GUNTUR, ANDHRA PRADESH, INDIA-522034, Sponsored by Chalapathi Institute of Pharmaceutical Sciences, Lam, CHALAPATHI NAGAR, LAM, GUNTUR, ANDHRA PRADESH, INDIA-522034. and GREYHOUND CHROMATOGRAPHY AND ALLIED CHEMICALS, 6 KELVIN PARK, BIRKENHEAD, MERSEYSIDE, CH41 1LT, UNITED KINGDOM. This partnership marks a significant step towards fostering industry-academic collaboration. I'm excited to have played a role in establishing this connection. Our MoU focuses on collaborative research, Webinars, Publication, and Patent and knowledge exchange, aiming to bring practical industry insights into academic research and provide real-world experience to students and research scholars. This collaboration is not just a milestone for CHALAPATHI DRUG TESTING LABORATORY (CDTL) and GREYHOUND CHROMATOGRAPHY AND ALLIED CHEMICALS but also a beacon for future industry-academia partnerships. It's a testament to what we can achieve when we combine the innovative minds at Greyhound Chromatography with the practical expertise of our team at CDTL. I extend my heartfelt thanks to RAMA RAO Nadendla Dr Victoria McOuat and Shiva P. and Special thanks to the directors of Greyhound Chromatography and the team involved in making this happen. Here's to a future of innovation, growth, and shared success!   #industryacademiacollaboration #Innovation #partnership #Chalapathi Institute of Pharmaceutical Sciences, Lam #mou #analyticalchemistry #research #HPLC #GC #Publication #Patent #Webinars #conferences #seminars #lcms #chromatography #Spectroscopy #analyticaldevelopment #methoddevelopment #bioanalysis #ftir #columns #Validation

One of the toughest challenges facing small molecule drug development today is poor solubility of the API. No single technique has universal application, so several strategies exist. Raj (Rajendran) Arunagiri examines 4 notable strategies in this article. https://lnkd.in/dwr23PmD #smallmolecule #drugdevelopment #API

Global Drug Discovery Services Market Revenue to Reach $41.3 billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐚𝐭 https://lnkd.in/dZgZxDp3 The size of global drug discovery services market in terms of revenue was estimated to be worth $20.6 billion in 2023 and is poised to reach $41.3 billion by 2028, growing at a CAGR of 14.9% from 2023 to 2028. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Laboratory Corporation of America Holdings Labcorp Charles River Laboratories WuXi AppTec Thermo Fisher Scientific Pharmaron Beijing Evotec Eurofins Scientific Finland Oy Piramal Enterprises Limited Syngene International Limited Curia Global GenScript Biotech Jubilant Pharmova Limited Frontage Laboratories, Inc Shanghai Medicilonic Inc. Aurigene Discovery Technologies (Dr. Reddy’s) Sygnature Discovery Oncodesign Services Selvita Viva Biotech TCG Lifesciences Pvt Ltd. Shanghai Chem Partner Domainex NUVISAN PHARMA SERVICES UK LTD Dalton Pharma Services Aragen Life Sciences Promega Corporation #DrugDiscoveryServices

Driving Factors for Growth in #Biosimilar Testing and Development Services Market The surge in demand for biosimilars as a cost-effective alternative to biological drugs, coupled with the rising prevalence of chronic diseases globally, is propelling the growth of the biosimilar testing and development services market.The biosimilar testing market size is expected to grow significantly, owing to a surge in the need for #biosimilartesting facilities to meet the growing demand for biosimilar medicines and the rise in outsourcing of preclinical, clinical, and laboratory testing services by pharma and biotech companies. Key Market Players: BioPharmaSpec, Profacgen , Element Materials Technology, Veeda Clinical Research Limited , SGS, INTERTEK GROUP PLC, Eurofins Scientific Finland Oy, Pacific BioLabs, Inc., Sartorius Want To Know More:https://lnkd.in/dH8ZWKK2 #BiosimilarMarket #BiologicalDrugs #ChronicDiseases #Healthcare #BiosimilarTesting #MedicalResearch #CancerStatistics #DrugDevelopment #HealthcareTrends #CostEffectiveMedicine

Drug Discovery Services Market Demands Worth to Reach $41.3 billion by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐚𝐭 https://lnkd.in/dMR9xw-c The size of global drug discovery services market in terms of revenue was estimated to be worth $20.6 billion in 2023 and is poised to reach $41.3 billion by 2028, growing at a CAGR of 14.9% from 2023 to 2028. Key Players: Laboratory Corporation of America Holdings Charles River Laboratories Clinical Services International Ltd WuXi AppTec Thermo Fisher Scientific Pharmaron Beijing Evotec Eurofins Scientific Finland Oy Piramal Enterprises Limited Syngene International Limited Curia Global Jubilant Pharmova Limited Frontage Laboratories, Inc Shanghai Medicilonic Inc. Aurigene Discovery Technologies Sygnature Discovery Oncodesign Services Selvita TCG Lifesciences Pvt Ltd. Domainex Dalton Pharma Services Aragen Life Sciences Promega Corporation